Moon, B., Cai, M., Lee, G., Zhao, T., Song, X., Giannotta, S. L., . . . Lu, W. (2020). Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma. J Clin Invest.
Style de citation ChicagoMoon, Byoung-San, Mingyang Cai, Grace Lee, Tong Zhao, Xiaofeng Song, Steven L. Giannotta, Frank J. Attenello, Min Yu, et Wange Lu. "Epigenetic Modulator Inhibition Overcomes Temozolomide Chemoresistance and Antagonizes Tumor Recurrence of Glioblastoma." J Clin Invest 2020.
Style de citation MLAMoon, Byoung-San, et al. "Epigenetic Modulator Inhibition Overcomes Temozolomide Chemoresistance and Antagonizes Tumor Recurrence of Glioblastoma." J Clin Invest 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.